We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sugar, Not Salt, at Heart of Cardiometabolic Disease

By HospiMedica International staff writers
Posted on 23 Dec 2014
A new study contends that dietary guidelines for treating hypertension and cardiovascular disease (CVD) should focus on reducing the amount of added sugars, primarily fructose, and not salt.

Researchers at Montefiore Medical Center (New York, NY, USA) and St. More...
Luke's Mid America Heart Institute (Kansas City, MO, USA) conducted a review of epidemiological studies and experimental trials in animals and humans and concluded that the evidence suggests that added sugars, particularly fructose from corn syrup, may increase blood pressure (BP) and BP variability, increase heart rate and myocardial oxygen demand, and contribute to inflammation, insulin resistance, and broader metabolic dysfunction.

They also suggest that while recommendations to reduce consumption of processed foods are highly appropriate and advisable, the benefits of such recommendations might have less to do with sodium—which is minimally related to BP and perhaps even inversely related to CVD risk—and more to do with highly-refined carbohydrates. They conclude that reduction in the intake of added sugars, particularly fructose, and specifically in the quantities and context of industrially-manufactured consumables, would help not only curb hypertension rates, but might also help address broader problems related to cardiometabolic disease. The review was published on December 10, 2014, in BMJ Open Heart.

“Recent data encompassing over 100,000 patients indicates that sodium intake between 3 and 6 gram per day is associated with a lower risk of death and cardiovascular events compared to either a higher or lower level of intake,” concluded study authors James Di Nicolantonio, MD, of Saint Luke's, and Sean Lucan, MD, of Montefiore Medical Center. “In fact, there is some evidence suggesting that reducing sodium intake could lead to worse health outcomes, such as increased cardiovascular and all-cause mortality in patients with diabetes, and increased hospitalizations and mortality in patients with congestive heart failure.”

“Just as most dietary sodium does not come from the salt shaker, most dietary sugar does not come from the sugar bowl; reducing consumption of added sugars by limiting processed foods containing it, made by corporations, would be a good place to start,” added the study authors. “The evidence is clear that even moderate doses of added sugar for short durations may cause substantial harm.”

Related Links:

St. Luke's Mid America Heart Institute
Montefiore Medical Center
Link to Hospimedica item on Salt study



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.